Above-average sized babies have a higher risk of autism and a lower risk of schizophrenia, while the opposite is true for below-average sized babies.
By modulating rather than completely blocking the dopamine receptor, a new class of drugs could treat schizophrenia with fewer side effects.
Mutations in fatty acid binding proteins resulting in disrupted lipid transport to the brain could be the common factor underlying both schizophrenia and autism.
The results of a genome-wide association study (GWAS) suggest that the immune system might be involved in schizophrenia.
A randomized clinical study has shown that estradiol alleviates symptoms of schizophrenia in women who were resistant to other forms of treatment.
Community intervention was found to be more effective at reducing symptoms and disabilities in schizophrenics compared to facility-based care.
LINE-1 retrotransposons are abnormally abundant in the schizophrenia brain and may be one of the causes of the disease, researchers say.
Scientists studying mouse models of schizophrenia have uncovered a faulty brain mechanism that may cause the psychiatric disorder in humans.
Researchers have discovered that the prevention and treatment of diabetes might help to reduce the cognitive impairment associated with schizophrenia.